HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3 Test
Components:
- Recipient: HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex
- HLA T & B cell lymphocyte cross match vs potential donor
- HLA Panel Reactive IgG antibodies Class I & Class II quantitative Luminex
- Donor specific IgG antibodies Class I & II Luminex
Price: 8310.0 AED
Sample Condition:
- RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (4 mL min.) serum from 2 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube.
- Collect specimen preferably 48 hours after dialysis.
- Ship refrigerated. DO NOT FREEZE.
- Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery: 10-12 days
Method: Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology
Test type: Transplantation
Doctor: Nephrologist
Test Department:
Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details:
The Sensitized Recipient Panel 3 (SRP3) test is a blood test used to determine the level of antibodies in a potential organ transplant recipient’s blood. This test is used to identify individuals who may have a higher risk of rejecting a transplanted organ due to pre-existing antibodies in their blood. The SRP3 test measures the level of antibodies in the recipient’s blood against a panel of donor cells. The donor cells are selected based on the frequency of their HLA (human leukocyte antigen) types in the general population. The test is typically performed on individuals who have previously received blood transfusions, multiple pregnancies, or previous organ transplants, as these experiences can lead to the development of antibodies in the blood. The results of the SRP3 test are used to determine the level of sensitization of the recipient, which can help guide the selection of a compatible donor organ for transplantation. If a potential donor organ is found to have a high level of HLA matching with the recipient’s antibodies, it may be a good match for transplantation. Overall, the SRP3 test is an important tool in the pre-transplant workup process, as it helps to identify potential barriers to successful transplantation and allows for better matching of donor organs with compatible recipients.
Test Name | HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3 Test |
---|---|
Components | Recipient : *HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex * HLA T & B cell lymphocyte cross match vs potential donor * HLA Panel Reactive IgG antibodies Class I & Class II quantitative Luminex * Donor specific IgG antibodies Class I & II Luminex |
Price | 8310.0 AED |
Sample Condition | RECIPIENT: 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube AND 9 mL (4 mL min.) serum from 2 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Collect specimen preferably 48 hours after dialysis.Ship refrigerated. DO NOT FREEZE. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
Report Delivery | 10-12 days |
Method | Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology |
Test type | Transplantation |
Doctor | Nephrologist |
Test Department: | |
Pre Test Information | Collect specimen preferably 48 hours after dialysis.Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
Test Details |
The Sensitized Recipient Panel 3 (SRP3) test is a blood test used to determine the level of antibodies in a potential organ transplant recipient’s blood. This test is used to identify individuals who may have a higher risk of rejecting a transplanted organ due to pre-existing antibodies in their blood. The SRP3 test measures the level of antibodies in the recipient’s blood against a panel of donor cells. The donor cells are selected based on the frequency of their HLA (human leukocyte antigen) types in the general population. The test is typically performed on individuals who have previously received blood transfusions, multiple pregnancies, or previous organ transplants, as these experiences can lead to the development of antibodies in the blood. The results of the SRP3 test are used to determine the level of sensitization of the recipient, which can help guide the selection of a compatible donor organ for transplantation. If a potential donor organ is found to have a high level of HLA matching with the recipient’s antibodies, it may be a good match for transplantation. Overall, the SRP3 test is an important tool in the pre-transplant workup process, as it helps to identify potential barriers to successful transplantation and allows for better matching of donor organs with compatible recipients. |